Menu
/REGISTER
Montecito
Giving Guide
PacPremier
Loading...
You are here:  Home  >  'Evenity'
Latest

Europeans nix Amgen’s Evenity over negative trial results

By   /  Friday, June 28th, 2019  /  Biotech, Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on Europeans nix Amgen’s Evenity over negative trial results

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen gets FDA approval for osteoporosis drug Evenity

By   /  Tuesday, April 9th, 2019  /  Biotech, Central Coast Health Watch, East Ventura County, Latest news, Technology  /  Comments Off on Amgen gets FDA approval for osteoporosis drug Evenity

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

FDA committee OKs Amgen’s Evenity

By   /  Thursday, January 17th, 2019  /  Biotech, Central Coast Health Watch, East Ventura County, Latest news  /  Comments Off on FDA committee OKs Amgen’s Evenity

A U.S. Food and Drug Administration advisory committee voted in favor of a new approval for Amgen’s osteoporosis treatment Evenity for use by postmenopausal women. The Bone, Reproductive and Urologic Drugs Advisory Committee voted to approve the expanded use of the treatment following the release of new safety and efficacy data and emphasized the need Read More →

Read More →
Latest

Amgen shares climb after it resubmits Evenity drug application to FDA

By   /  Friday, July 13th, 2018  /  Central Coast Health Watch, East Ventura County, Latest news, Tri-County Public Companies  /  Comments Off on Amgen shares climb after it resubmits Evenity drug application to FDA

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →